ICM
CCXI

Ionic Capital Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Ionic Capital Management’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-9,896
Closed -$133K – 430
2021
Q2 		$133K Buy
+9,896
New +$244K 0.01% 324

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Ionic Capital Management's CCXI Position: Q3 2021 in Review

Ionic Capital Management sold out of ChemoCentryx, Inc. (CCXI) in Q3 2021, closing a stake of 9,896 shares — an estimated $133K sold.

Ionic Capital Management first reported a position in CCXI in Q2 2021 and held it in 1 quarter. The position peaked at $133K in Q2 2021. 140 funds tracked by Wall St. Rank hold CCXI as of Q3 2021.

  • Ionic Capital Management reported no remaining ChemoCentryx, Inc. position as of Q3 2021 after selling out during the quarter.
  • Ionic Capital Management sold 9,896 ChemoCentryx, Inc. shares in Q3 2021, an estimated $133K.
  • Ionic Capital Management first reported a position in ChemoCentryx, Inc. in Q2 2021 and held it in 1 quarter.
  • Ionic Capital Management's ChemoCentryx, Inc. position peaked at $133K in Q2 2021.
  • 140 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2021.

Based on Ionic Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.